BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30743007)

  • 1. Health Care Utilization and Costs for Patients With End-Stage Liver Disease Are Significantly Higher at the End of Life Compared to Those of Other Decedents.
    Kelly EM; James PD; Murthy S; Antonova L; Wong F; Shaw-Stiffel T; Chalifoux M; Salim M; Tanuseputro P
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2339-2346.e1. PubMed ID: 30743007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-Based Estimates of Health Care Utilization and Expenditures by Adults During the Last 2 Years of Life in Canada's Single-Payer Health System.
    Rosella LC; Kornas K; Bornbaum C; Huang A; Watson T; Shuldiner J; Wodchis WP
    JAMA Netw Open; 2020 Apr; 3(4):e201917. PubMed ID: 32236531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.
    Murthy SK; James PD; Antonova L; Chalifoux M; Tanuseputro P
    PLoS One; 2017; 12(5):e0177211. PubMed ID: 28498877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The health care cost of dying: a population-based retrospective cohort study of the last year of life in Ontario, Canada.
    Tanuseputro P; Wodchis WP; Fowler R; Walker P; Bai YQ; Bronskill SE; Manuel D
    PLoS One; 2015; 10(3):e0121759. PubMed ID: 25811195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dying of amyotrophic lateral sclerosis: Health care use and cost in the last year of life.
    Zwicker J; Qureshi D; Talarico R; Bourque P; Scott M; Chin-Yee N; Tanuseputro P
    Neurology; 2019 Dec; 93(23):e2083-e2093. PubMed ID: 31672715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Children's End-of-Life Health Care Use and Cost.
    Widger K; Seow H; Rapoport A; Chalifoux M; Tanuseputro P
    Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28255066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection.
    Gordon SC; Pockros PJ; Terrault NA; Hoop RS; Buikema A; Nerenz D; Hamzeh FM
    Hepatology; 2012 Nov; 56(5):1651-60. PubMed ID: 22610658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Till death do us part: the effect of marital status on health care utilization and costs at end-of-life. A register study on all colorectal cancer decedents in Norway between 2009 and 2013.
    Bjørnelv GMW; Edwin B; Fretland ÅA; Deb P; Aas E
    BMC Health Serv Res; 2020 Feb; 20(1):115. PubMed ID: 32054492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries.
    Bekelman JE; Halpern SD; Blankart CR; Bynum JP; Cohen J; Fowler R; Kaasa S; Kwietniewski L; Melberg HO; Onwuteaka-Philipsen B; Oosterveld-Vlug M; Pring A; Schreyögg J; Ulrich CM; Verne J; Wunsch H; Emanuel EJ;
    JAMA; 2016 Jan; 315(3):272-83. PubMed ID: 26784775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dying with Parkinson's Disease: Healthcare Utilization and Costs in the Last Year of Life.
    Zwicker J; Qureshi D; Talarico R; Webber C; Watt C; Kim W; Milani C; Ramanathan U; Mestre T; Tanuseputro P
    J Parkinsons Dis; 2022; 12(7):2249-2259. PubMed ID: 36120791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical care at the end of life: a population-level cohort study of cost and outcomes.
    Chaudhuri D; Tanuseputro P; Herritt B; D'Egidio G; Chalifoux M; Kyeremanteng K
    Crit Care; 2017 May; 21(1):124. PubMed ID: 28558826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Immigrant Status and End-of-Life Care in Ontario, Canada.
    Yarnell CJ; Fu L; Manuel D; Tanuseputro P; Stukel T; Pinto R; Scales DC; Laupacis A; Fowler RA
    JAMA; 2017 Oct; 318(15):1479-1488. PubMed ID: 28973088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-of-life care in individuals with respiratory diseases: a population study comparing the dying experience between those with chronic obstructive pulmonary disease and lung cancer.
    Kendzerska T; Nickerson JW; Hsu AT; Gershon AS; Talarico R; Mulpuru S; Pakhale S; Tanuseputro P
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1691-1701. PubMed ID: 31534323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Primary Care Model Effect Healthcare at the End of Life? A Population-Based Retrospective Cohort Study.
    Howard M; Chalifoux M; Tanuseputro P
    J Palliat Med; 2017 Apr; 20(4):344-351. PubMed ID: 27893954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resource use, costs and quality of end-of-life care: observations in a cohort of elderly Australian cancer decedents.
    Langton JM; Srasuebkul P; Reeve R; Parkinson B; Gu Y; Buckley NA; Haas M; Viney R; Pearson SA;
    Implement Sci; 2015 Feb; 10():25. PubMed ID: 25884470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes and Health Care Utilization after Prolonged Mechanical Ventilation.
    Hill AD; Fowler RA; Burns KE; Rose L; Pinto RL; Scales DC
    Ann Am Thorac Soc; 2017 Mar; 14(3):355-362. PubMed ID: 28033033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International comparison of spending and utilization at the end of life for hip fracture patients.
    Blankart CR; van Gool K; Papanicolas I; Bernal-Delgado E; Bowden N; Estupiñán-Romero F; Gauld R; Knight H; Abiona O; Riley K; Schoenfeld AJ; Shatrov K; Wodchis WP; Figueroa JF;
    Health Serv Res; 2021 Dec; 56 Suppl 3(Suppl 3):1370-1382. PubMed ID: 34490633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Population-Based Study of Care at the End of Life Among People With HIV in Ontario From 2010 to 2013.
    Kendall CE; Chalifoux M; Manuel D; Reinhard R; Robinson G; Bacon J; Rourke SB; Rosenes R; Tanuseputro P
    J Acquir Immune Defic Syndr; 2017 May; 75(1):e1-e7. PubMed ID: 27984556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease.
    Gordon SC; Hamzeh FM; Pockros PJ; Hoop RS; Buikema AR; Korner EJ; Terrault NA
    Aliment Pharmacol Ther; 2013 Oct; 38(7):784-93. PubMed ID: 23981040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer.
    Obermeyer Z; Makar M; Abujaber S; Dominici F; Block S; Cutler DM
    JAMA; 2014 Nov; 312(18):1888-96. PubMed ID: 25387186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.